IL27 and neoplasm: Indeed, in IL-30-/+ and IL-30−/−tumors, the F4/80 macrophage and IDO+CD11b+Gr-1+ myeloid cell content was somewhat depleted, which in itself compromises tumor angiogenesis and alleviates suppression of T cell activity [30].